SCHEMBL29401299

SCHEMBL29401299

CC(Cc1ccccc1)NC(=O)OC(C)(C)C

nearest known ligand 0.63

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.63
RAB9A P51151 2/20 0.63
ATM Q13315 1/20 0.63
CTSS P25774 3/20 0.60
CTSK P43235 2/20 0.60
CTSL P07711 1/20 0.60
CTSB P07858 1/20 0.60
ACE P12821 1/20 0.57
LMNA P02545 1/20 0.55
KLK5 Q9Y337 2/20 0.54
TAAR1 Q96RJ0 1/20 0.54
PPARA Q07869 2/20 0.52
PPARG P37231 1/20 0.52
AKT1 P31749 1/20 0.52
APP P05067 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12203694 1.00 NPC1 (0.63) NPC1RAB9AATMCTSSCTSK
SCHEMBL3676162 1.00 NPC1 (0.63) NPC1RAB9AATMCTSSCTSK
SCHEMBL3676166 1.00 NPC1 (0.63) NPC1RAB9AATMCTSSCTSK
Dimethylamine SCHEMBL1435916 0.97 ATM (0.60) NPC1RAB9AATMCTSSCTSK
SCHEMBL18569400 0.94 PPARA (0.60) NPC1RAB9AATMCTSSCTSK
SCHEMBL14884499 0.91 CTSS (0.65) NPC1RAB9AATMCTSSCTSK
SCHEMBL13823611 0.90 CTSS (0.57) NPC1RAB9AATMCTSSCTSK
SCHEMBL22962299 0.89 CTSS (0.70) ATMCTSSCTSKCTSLCTSB
SCHEMBL10135746 0.89 CTSS (0.70) ATMCTSSCTSKCTSLCTSB
SCHEMBL19930027 0.88 BCL2 (0.59) ATMCTSSACEPPARAPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117402085-A Novel method for synthesizing D-N-BOC-biphenylpropylamine 迪嘉药业集团股份有限公司 2024-01-16 CN claimed
CN-117402085-A Novel method for synthesizing D-N-BOC-biphenylpropylamine 迪嘉药业集团股份有限公司 2024-01-16 CN disclosed
CN-114072205-A Method of treating hypertension with TIE-2 activator 视点制药公司 2022-02-18 CN disclosed